192 related articles for article (PubMed ID: 29192701)
21. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
[TBL] [Abstract][Full Text] [Related]
22. Gold(I)-NHC complexes of antitumoral diarylimidazoles: structures, cellular uptake routes and anticancer activities.
Kaps L; Biersack B; Müller-Bunz H; Mahal K; Münzner J; Tacke M; Mueller T; Schobert R
J Inorg Biochem; 2012 Jan; 106(1):52-8. PubMed ID: 22112840
[TBL] [Abstract][Full Text] [Related]
23. Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma.
Lopes-Nunes J; Lifante J; Shen Y; Ximendes EC; Jaque D; Iglesias-de la Cruz MC; Cruz C
Eur J Pharm Biopharm; 2020 Sep; 154():228-235. PubMed ID: 32707287
[TBL] [Abstract][Full Text] [Related]
24. Aptamer-mediated synthesis of multifunctional nano-hydroxyapatite for active tumour bioimaging and treatment.
Zhang W; Zhou R; Yang Y; Peng S; Xiao D; Kong T; Cai X; Zhu B
Cell Prolif; 2021 Sep; 54(9):e13105. PubMed ID: 34382270
[TBL] [Abstract][Full Text] [Related]
25. AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.
Wang H; Zhu Z; Zhang G; Lin F; Liu Y; Zhang Y; Feng J; Chen W; Meng Q; Chen L
J Pharm Sci; 2019 Nov; 108(11):3684-3694. PubMed ID: 31465736
[TBL] [Abstract][Full Text] [Related]
26. Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell.
Lohlamoh W; Soontornworajit B; Rotkrua P
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2209-219. PubMed ID: 34319045
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
[TBL] [Abstract][Full Text] [Related]
28. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional Au
Zhang J; Zou H; Lei J; He B; He X; Sung HHY; Kwok RTK; Lam JWY; Zheng L; Tang BZ
Angew Chem Int Ed Engl; 2020 Apr; 59(18):7097-7105. PubMed ID: 32049411
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic applications of AS1411 aptamer, an update review.
Yazdian-Robati R; Bayat P; Oroojalian F; Zargari M; Ramezani M; Taghdisi SM; Abnous K
Int J Biol Macromol; 2020 Jul; 155():1420-1431. PubMed ID: 31734366
[TBL] [Abstract][Full Text] [Related]
31. Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides.
Śmiłowicz D; Slootweg JC; Metzler-Nolte N
Mol Pharm; 2019 Nov; 16(11):4572-4581. PubMed ID: 31596097
[TBL] [Abstract][Full Text] [Related]
32. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
[TBL] [Abstract][Full Text] [Related]
33. Combination of Doxorubicin with Gemcitabine-Incorporated G-Quadruplex Aptamer Showed Synergistic and Selective Anticancer Effect in Breast Cancer Cells.
Joshi M; Choi JS; Park JW; Doh KO
J Microbiol Biotechnol; 2019 Nov; 29(11):1799-1805. PubMed ID: 31546295
[TBL] [Abstract][Full Text] [Related]
34. Enhanced cytotoxicity of silver complexes bearing bidentate N-heterocyclic carbene ligands.
Monteiro DC; Phillips RM; Crossley BD; Fielden J; Willans CE
Dalton Trans; 2012 Apr; 41(13):3720-5. PubMed ID: 22327273
[TBL] [Abstract][Full Text] [Related]
35. Pharmacomodulation on Gold-NHC complexes for anticancer applications - is lipophilicity the key point?
Zhang C; Maddelein ML; Wai-Yin Sun R; Gornitzka H; Cuvillier O; Hemmert C
Eur J Med Chem; 2018 Sep; 157():320-332. PubMed ID: 30099254
[TBL] [Abstract][Full Text] [Related]
36. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
[TBL] [Abstract][Full Text] [Related]
37. Characterizing Oligonucleotide Uptake in Cultured Cells: A Case Study Using AS1411 Aptamer.
Reyes-Reyes EM; Bates PJ
Methods Mol Biol; 2019; 2036():173-186. PubMed ID: 31410797
[TBL] [Abstract][Full Text] [Related]
38. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
[TBL] [Abstract][Full Text] [Related]
39. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.
Bates PJ; Reyes-Reyes EM; Malik MT; Murphy EM; O'Toole MG; Trent JO
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1414-1428. PubMed ID: 28007579
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, characterization, and biological studies of multidentate gold(i) and gold(iii) NHC complexes.
Bauer EB; Bernd MA; Schütz M; Oberkofler J; Pöthig A; Reich RM; Kühn FE
Dalton Trans; 2019 Nov; 48(44):16615-16625. PubMed ID: 31657405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]